Literature DB >> 22905719

Mammalian PER2 regulates AKT activation and DNA damage response.

Xiaoming Yang1, Xuezhong He, Zhengguan Yang, Esmaiel Jabbari.   

Abstract

PER2 is a key mammalian circadian clock protein. It also has a tumor suppressive function. Down regulation of PER2 in the cultured cancer cells accelerates cell proliferation, while overexpression of PER2 inhibits cell growth and induces apoptosis. The Per2 mutant mice have a cancer prone phenotype and an altered DNA damage response. Here we report that PER2 regulates AKT activity. Cells with down-regulated PER2 expression have prolonged high levels of AKT T308 phosphorylation after growth factor stimulation or DNA damage. PER2 down-regulation delays DNA damage induced Chk2 activation and overrides DNA damage induced apoptosis and cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22905719     DOI: 10.1139/o2012-025

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  10 in total

Review 1.  Cancer and the Circadian Clock.

Authors:  Ayesha A Shafi; Karen E Knudsen
Journal:  Cancer Res       Date:  2019-07-12       Impact factor: 12.701

2.  Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells.

Authors:  Bo Chen; Yaoxi Tan; Yan Liang; Yan Li; Lei Chen; Shuangshuang Wu; Wei Xu; Yan Wang; Weihong Zhao; Jianqing Wu
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

3.  Effect of Period 2 on the proliferation, apoptosis and migration of osteosarcoma cells, and the corresponding mechanisms.

Authors:  Tao Qin; Xiao-Ting Lu; Yong-Gang Li; Yan Liu; Wenjiang Yan; Na Li; Yuan-Yuan Sun
Journal:  Oncol Lett       Date:  2018-06-12       Impact factor: 2.967

4.  Genomic deletion of GIT2 induces a premature age-related thymic dysfunction and systemic immune system disruption.

Authors:  Sana Siddiqui; Ana Lustig; Arnell Carter; Mathavi Sankar; Caitlin M Daimon; Richard T Premont; Harmonie Etienne; Jaana van Gastel; Abdelkrim Azmi; Jonathan Janssens; Kevin G Becker; Yongqing Zhang; William Wood; Elin Lehrmann; James G Martin; Bronwen Martin; Dennis D Taub; Stuart Maudsley
Journal:  Aging (Albany NY)       Date:  2017-03-04       Impact factor: 5.682

Review 5.  Current Status of Research on the Period Family of Clock Genes in the Occurrence and Development of Cancer.

Authors:  Fan Deng; Kai Yang
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

6.  Regulation of Microcystin-LR-Induced DNA Damage by miR-451a in HL7702 Cells.

Authors:  Lv Chen; Shu Yang; Cong Wen; Shuilin Zheng; Yue Yang; Xiangling Feng; Jihua Chen; Dan Luo; Ran Liu; Fei Yang
Journal:  Toxins (Basel)       Date:  2019-03-15       Impact factor: 4.546

Review 7.  The role of circadian clock genes in tumors.

Authors:  Han-Xue Li
Journal:  Onco Targets Ther       Date:  2019-05-13       Impact factor: 4.147

Review 8.  Targeting circadian PER2 as therapy in myocardial ischemia and reperfusion injury.

Authors:  Yoshimasa Oyama; Lori A Walker; Tobias Eckle
Journal:  Chronobiol Int       Date:  2021-05-25       Impact factor: 3.749

9.  Period2 downregulation inhibits glioma cell apoptosis by activating the MDM2-TP53 pathway.

Authors:  Niu Zhanfeng; Wang Chengquan; Xia Hechun; Wang Jun; Zhang Lijian; Ma Dede; Liu Wenbin; Yin Lei
Journal:  Oncotarget       Date:  2016-05-10

10.  PER2 inhibits proliferation and stemness of glioma stem cells via the Wnt/β‑catenin signaling pathway.

Authors:  Dede Ma; Li Hou; Hechun Xia; Hailiang Li; Heng Fan; Xiaoxiong Jia; Zhanfeng Niu
Journal:  Oncol Rep       Date:  2020-05-27       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.